Insider transaction 📈 Stocks 🌍 United States

HeartFlow CEO John Farquhar Sells 38,900 Shares in Pre-Planned Transaction

CEO John Farquhar offloaded $1.8 million in HeartFlow stock via a Rule 10b5-1 plan, maintaining a significant 321,914-share stake as the company boosts its 2026 sales forecast.

📅 September 15, 2026 🕐 1 min read

1 assets impacted. Net bias: 0 Bullish, 0 Bearish, 1 Neutral. Strongest signal: HTFL → 3/10 (60% confidence).

📊 Affected Assets (1)

HTFL

Neutral 🤖 60%

📅 Short-term 🌍 US · Explicit

CEO sold shares under a pre-existing Rule 10b5-1 plan while the company raised full-year guidance, resulting in a neutral outlook.

🎯 Key Takeaways

CEO John Farquhar sold 38,900 shares at a weighted average price of $46.78.
The sale was conducted via a Rule 10b5-1 plan, indicating a pre-scheduled, non-discretionary transaction.
HeartFlow raised its 2026 full-year revenue guidance to a range of $246 million to $250 million.
The company reported a 48% year-over-year revenue increase in the second quarter.

📝 Executive Summary

HeartFlow CEO John C.M. Farquhar sold 38,900 shares of common stock for approximately $1.8 million on September 14, 2026. The transaction was executed under a pre-existing Rule 10b5-1 trading plan, signaling a non-discretionary move rather than a shift in company outlook as HeartFlow raises its full-year revenue guidance.

❓ FAQ

Does the CEO's share sale indicate a lack of confidence in HeartFlow?

No, the sale was executed under a pre-existing Rule 10b5-1 trading plan established in 2025, which is a non-discretionary mechanism used to avoid insider trading concerns.

📰 Related Articles

🏷️ Tags

📰 Source

🔗 View Original Article